Researchers identify mechanism that causes gastrointestinal problems with cancer immunotherapy

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment.

Related Keywords

Canada ,Michigan ,United States ,Canadian ,Naohiro Inohara ,Jiali Yu ,Weiping Zou ,Masanori Matsumoto ,Ilona Kryczek ,Ryosuke Sato ,Gabriel Nunez ,Linda Vatan ,Roberta Caruso ,Michaelh Shaw ,Yuying Xie ,Colitis Foundation ,Takeda Millennium Pharmaceuticals ,University Of Michigan Health Rogel Cancer Center ,University Of Michigan ,National Institutes Of Health ,Canadian Institutes Of Health ,National Science Foundation ,Takeda Pharmaceuticals ,Rogel Cancer Center Shared Resources ,Michigan Health Rogel Cancer Center ,Senior Study Author ,Paul De Kruif Professor ,National Institutes ,Canadian Institutes ,Single Cell Spatial Analysis ,Cancer ,Immunotherapy ,Antibodies ,Cancer Treatment ,D4 ,Fell ,Ctla 4 ,Medicine ,Ouse Model ,Pathology ,Pharmaceuticals ,Research ,Humor ,